The effect of intravenous cyclosporine on rates of colonic surgery in hospitalized patients with severe Crohn's colitis

Mark Lazarev, Daniel H. Present, Simon Lichtiger, Asher Kornbluth, James Marion, Mark Chapman, Thomas A. Ullman

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

BACKGROUND: The role of intravenous (IV) cyclosporine in severe Crohn's colitis (CC) is poorly studied. AIM: Our primary aim was to determine the in-hospital colonic resection rate in patients with severe CC who received IV cyclosporine, and the potential predictors of resection among these patients. METHODS: An inpatient pharmacy query of all patients who received IV cyclosporine at Mount Sinai Medical Center for 12.5 years after January 1, 1996 was reviewed. Patients with CC or indeterminate colitis favoring Crohn's were included and their medical records were reviewed. Subsequent need for colonic surgery was assessed. A Kaplan-Meier plot with log-rank testing was performed to determine the rate of colonic surgery avoidance. Forward stepwise logistic regression was performed to determine independent predictors of surgery. RESULTS: Forty-eight patients met our inclusion criteria. Prior thiopurine and anti-tumor necrosis factor (anti-TNF) use was 85% and 69%, respectively. The median follow-up time was 12 months (range, 1 to 60 mo). 12.5% of patients required colonic resection during their admission for IV cyclosporine. Anti-TNF use in the 4 weeks preceding IV cyclosporine was the only predictor of surgery in this setting (P=0.05). The cumulative colonic surgery avoidance rate was 72±13% at 6 months and 59±15% at 12 months. CONCLUSIONS: The use of IV cyclosporine resulted in a low rate of in-hospitalization colonic surgery among CC patients with severe disease, the majority of whom previously failed anti-TNFs and thiopurines.

Original languageEnglish (US)
Pages (from-to)764-767
Number of pages4
JournalJournal of Clinical Gastroenterology
Volume46
Issue number9
DOIs
StatePublished - Oct 1 2012
Externally publishedYes

Fingerprint

Colitis
Cyclosporine
Medical Records
Inpatients
Hospitalization
Tumor Necrosis Factor-alpha
Logistic Models

Keywords

  • colectomy
  • colitis
  • Crohn's disease
  • cyclosporine

ASJC Scopus subject areas

  • Gastroenterology

Cite this

The effect of intravenous cyclosporine on rates of colonic surgery in hospitalized patients with severe Crohn's colitis. / Lazarev, Mark; Present, Daniel H.; Lichtiger, Simon; Kornbluth, Asher; Marion, James; Chapman, Mark; Ullman, Thomas A.

In: Journal of Clinical Gastroenterology, Vol. 46, No. 9, 01.10.2012, p. 764-767.

Research output: Contribution to journalArticle

Lazarev, Mark ; Present, Daniel H. ; Lichtiger, Simon ; Kornbluth, Asher ; Marion, James ; Chapman, Mark ; Ullman, Thomas A. / The effect of intravenous cyclosporine on rates of colonic surgery in hospitalized patients with severe Crohn's colitis. In: Journal of Clinical Gastroenterology. 2012 ; Vol. 46, No. 9. pp. 764-767.
@article{aad219536f8d410bb7342d06fef4d588,
title = "The effect of intravenous cyclosporine on rates of colonic surgery in hospitalized patients with severe Crohn's colitis",
abstract = "BACKGROUND: The role of intravenous (IV) cyclosporine in severe Crohn's colitis (CC) is poorly studied. AIM: Our primary aim was to determine the in-hospital colonic resection rate in patients with severe CC who received IV cyclosporine, and the potential predictors of resection among these patients. METHODS: An inpatient pharmacy query of all patients who received IV cyclosporine at Mount Sinai Medical Center for 12.5 years after January 1, 1996 was reviewed. Patients with CC or indeterminate colitis favoring Crohn's were included and their medical records were reviewed. Subsequent need for colonic surgery was assessed. A Kaplan-Meier plot with log-rank testing was performed to determine the rate of colonic surgery avoidance. Forward stepwise logistic regression was performed to determine independent predictors of surgery. RESULTS: Forty-eight patients met our inclusion criteria. Prior thiopurine and anti-tumor necrosis factor (anti-TNF) use was 85{\%} and 69{\%}, respectively. The median follow-up time was 12 months (range, 1 to 60 mo). 12.5{\%} of patients required colonic resection during their admission for IV cyclosporine. Anti-TNF use in the 4 weeks preceding IV cyclosporine was the only predictor of surgery in this setting (P=0.05). The cumulative colonic surgery avoidance rate was 72±13{\%} at 6 months and 59±15{\%} at 12 months. CONCLUSIONS: The use of IV cyclosporine resulted in a low rate of in-hospitalization colonic surgery among CC patients with severe disease, the majority of whom previously failed anti-TNFs and thiopurines.",
keywords = "colectomy, colitis, Crohn's disease, cyclosporine",
author = "Mark Lazarev and Present, {Daniel H.} and Simon Lichtiger and Asher Kornbluth and James Marion and Mark Chapman and Ullman, {Thomas A.}",
year = "2012",
month = "10",
day = "1",
doi = "10.1097/MCG.0b013e31824e14a8",
language = "English (US)",
volume = "46",
pages = "764--767",
journal = "Journal of Clinical Gastroenterology",
issn = "0192-0790",
publisher = "Lippincott Williams and Wilkins",
number = "9",

}

TY - JOUR

T1 - The effect of intravenous cyclosporine on rates of colonic surgery in hospitalized patients with severe Crohn's colitis

AU - Lazarev, Mark

AU - Present, Daniel H.

AU - Lichtiger, Simon

AU - Kornbluth, Asher

AU - Marion, James

AU - Chapman, Mark

AU - Ullman, Thomas A.

PY - 2012/10/1

Y1 - 2012/10/1

N2 - BACKGROUND: The role of intravenous (IV) cyclosporine in severe Crohn's colitis (CC) is poorly studied. AIM: Our primary aim was to determine the in-hospital colonic resection rate in patients with severe CC who received IV cyclosporine, and the potential predictors of resection among these patients. METHODS: An inpatient pharmacy query of all patients who received IV cyclosporine at Mount Sinai Medical Center for 12.5 years after January 1, 1996 was reviewed. Patients with CC or indeterminate colitis favoring Crohn's were included and their medical records were reviewed. Subsequent need for colonic surgery was assessed. A Kaplan-Meier plot with log-rank testing was performed to determine the rate of colonic surgery avoidance. Forward stepwise logistic regression was performed to determine independent predictors of surgery. RESULTS: Forty-eight patients met our inclusion criteria. Prior thiopurine and anti-tumor necrosis factor (anti-TNF) use was 85% and 69%, respectively. The median follow-up time was 12 months (range, 1 to 60 mo). 12.5% of patients required colonic resection during their admission for IV cyclosporine. Anti-TNF use in the 4 weeks preceding IV cyclosporine was the only predictor of surgery in this setting (P=0.05). The cumulative colonic surgery avoidance rate was 72±13% at 6 months and 59±15% at 12 months. CONCLUSIONS: The use of IV cyclosporine resulted in a low rate of in-hospitalization colonic surgery among CC patients with severe disease, the majority of whom previously failed anti-TNFs and thiopurines.

AB - BACKGROUND: The role of intravenous (IV) cyclosporine in severe Crohn's colitis (CC) is poorly studied. AIM: Our primary aim was to determine the in-hospital colonic resection rate in patients with severe CC who received IV cyclosporine, and the potential predictors of resection among these patients. METHODS: An inpatient pharmacy query of all patients who received IV cyclosporine at Mount Sinai Medical Center for 12.5 years after January 1, 1996 was reviewed. Patients with CC or indeterminate colitis favoring Crohn's were included and their medical records were reviewed. Subsequent need for colonic surgery was assessed. A Kaplan-Meier plot with log-rank testing was performed to determine the rate of colonic surgery avoidance. Forward stepwise logistic regression was performed to determine independent predictors of surgery. RESULTS: Forty-eight patients met our inclusion criteria. Prior thiopurine and anti-tumor necrosis factor (anti-TNF) use was 85% and 69%, respectively. The median follow-up time was 12 months (range, 1 to 60 mo). 12.5% of patients required colonic resection during their admission for IV cyclosporine. Anti-TNF use in the 4 weeks preceding IV cyclosporine was the only predictor of surgery in this setting (P=0.05). The cumulative colonic surgery avoidance rate was 72±13% at 6 months and 59±15% at 12 months. CONCLUSIONS: The use of IV cyclosporine resulted in a low rate of in-hospitalization colonic surgery among CC patients with severe disease, the majority of whom previously failed anti-TNFs and thiopurines.

KW - colectomy

KW - colitis

KW - Crohn's disease

KW - cyclosporine

UR - http://www.scopus.com/inward/record.url?scp=84866245046&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84866245046&partnerID=8YFLogxK

U2 - 10.1097/MCG.0b013e31824e14a8

DO - 10.1097/MCG.0b013e31824e14a8

M3 - Article

C2 - 22751334

AN - SCOPUS:84866245046

VL - 46

SP - 764

EP - 767

JO - Journal of Clinical Gastroenterology

JF - Journal of Clinical Gastroenterology

SN - 0192-0790

IS - 9

ER -